帕金森病中的非突触可塑性:来自动物模型的见解
Mônica P C Viegas1, Luiz E C Santos1, Mayra C Aarão1
1Laboratory of Experimental and Computational Neuroscience, Department of Biosystems Engineering, Universidade Federal de São João del-Rei (UFSJ), São João del-Rei, MG, Brazil.
Clinics (Sao Paulo, Brazil)
|July 22, 2023
概括
在大鼠中的6-OHDA损伤模型显示了质激活和改变的连xin-36表达,但没有改变离子载体. 这些发现表明非突触机制可能会影响帕金森氏症.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 神经退行发生神经退行.
背景情况:
- 六二多巴胺 (6-OHDA) 低层病变模型与神经网络刺激性和同步性障碍有关.
- 该模型还显示了调节离子度和质增殖的跨膜蛋白的改变表达.
- 这些非突触机制与神经元损伤和网络超同步有关.
研究的目的:
- 为了研究是否非突触机制,除了直接的神经传输,调节内三角管路径.
- 探索质激活和特定蛋白质表达在对6-OHDA诱导病变的反应中的作用.
主要方法:
- 雄性Wistar大鼠接受了单边条纹性6-OHDA注射或盐水控制.
- 用光学密度计量对GFAP,NKCC1,KCC2,Na+/K+-ATPase,TH和Cx36的免疫活性进行了量化.
主要成果:
- 6-OHDA病变诱导了受损和相邻的黑腹部区域的星细胞反应.
- 没有观察到阴离子合载体 (NKCC1,KCC2) 或Na+/K+-ATPase表达的显著变化.
- 多巴氨基性退化与连xin-36 (Cx36) 的表达变化相关.
结论:
- 非突触机制,包括质反应和改变的连xin-36表达,都涉及到6-OHDA nigrostriatal损伤模型.
- 需要进一步的电生理学研究来证实帕金森病模型中神经元同步的变化.
- 通过阻塞剂准间隙结 (GJ) 是一种潜在的策略,用于管理帕金森病的运动症状.
相关概念视频
Parkinson's Disease: Overview
601
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
601
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Parkinson's Disease: Treatment
301
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
301


